Treatment for autism

Efficacy and Safety of IMPUTE ADT-1 in children with autism spectrum disorder aged 2-6 years: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/02/050044

Enrollment

102

Registered

2023-02-24

Start date

Unknown

Completion date

Unknown

Last updated

2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: Applied behavior analysis provided by a mobile medical application named IMPUTE ADT-1: Applied behavior analysis will be provided for 6 months by making the child use the mobile medical

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of autism spectrum disorder as per Autism Diagnostic Observation Schedule Second Edition (ADOS-2) Parents willing to comply with the treatment for 6-months and regular follow up

Exclusion criteria

Exclusion criteria: Persons with uncontrolled epilepsy Hearing or vision impairment

Design outcomes

Primary

Measure	Time frame
Change in Autism Diagnostic Observation Schedule-2 (ADOS-2) total scoreTimepoint: At baseline (0 month) and at 6 months	—

Secondary

Measure	Time frame
Change in Autism Diagnostic Interview-Revised (ADI-R) total scoreTimepoint: At baseline (0 month) and at 6 months;Change in Social Responsiveness Scale-2(SRS-2) scoreTimepoint: At baseline (0 month) and at 6 months	—

Countries

India

Contacts

Public ContactPRATEEK KUMAR PANDA

AIIMS, RISHIKESH

drprateekpanda@gmail.com9650149735

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026